Prostatic Involvement in Men with Febrile Urinary Tract Infection As Measured by Serum Prostate-specific Antigen and Transrectal Ultrasonography
Affiliations
Objective: To determine the frequency of prostatic involvement in men with community-acquired febrile urinary tract infection.
Patients And Methods: This prospective study included 70 men (18-85 years old) who had a fever of >/=38.0 degrees C, symptoms or signs of urinary tract infection and a positive urine culture. Serum prostate-specific antigen (PSA) was measured and transrectal ultrasonography of the prostate and seminal vesicles performed during the acute phase of the disease and during a 1-year follow-up.
Results: Although only six patients had a tender prostate on digital rectal examination, the initial serum PSA level was elevated in 58 (83%) patients (median 14 ng/mL, range 0.54-140). There was no correlation between PSA levels, patient age, inflammatory response to infection or presence of positive blood cultures. Despite a rapid decline in PSA level after one month, there was a protracted decrease in some patients. After 3 months the median prostate volume was reduced by 31% (range 11-54; P<0.001) in 46 of 55 patients examined, and the width of the right and left seminal vesicle was reduced by 14% and 22%, respectively. The reductions in PSA and prostate volume were significantly correlated (r=0.36, 95% confidence interval 0.09-0.58; P=0.01).
Conclusion: These results show that the prostate and seminal vesicles are frequently involved in men with febrile urinary tract infection and that PSA may be a useful marker of prostatic infection. The slow decline of PSA levels in some patients after appropriate antibiotic treatment indicates a protracted healing process and should be considered when PSA is used to detect prostate cancer.
Ruiz-Lievano A, Cervantes-Flores F, Nava-Torres A, Carbajal-Morales P, Villasenor-Garcia L, Zavala-Cerna M Microorganisms. 2024; 12(11).
PMID: 39597709 PMC: 11596487. DOI: 10.3390/microorganisms12112320.
[What is confirmed in therapy of complicated urinary tract infections].
von Vietinghoff S, Wagenlehner F Inn Med (Heidelb). 2024; 65(12):1180-1187.
PMID: 39331061 DOI: 10.1007/s00108-024-01792-2.
Extremely Elevated Prostate-Specific Antigen in Acute Prostatitis: A Case Report.
Nepal A, Sharma P, Bhattarai S, Mahajan Z, Sharma A, Sapkota A Cureus. 2023; 15(8):e43730.
PMID: 37727194 PMC: 10505831. DOI: 10.7759/cureus.43730.
OConnell S, Frantzi M, Latosinska A, Webb M, Mullen W, Pejchinovski M Cancers (Basel). 2022; 14(8).
PMID: 35454901 PMC: 9027643. DOI: 10.3390/cancers14081995.
Taniguchi T, Tsuha S, Shiiki S, Narita M BMC Infect Dis. 2022; 22(1):198.
PMID: 35227212 PMC: 8886832. DOI: 10.1186/s12879-022-07194-9.